Photo = Getty Image Bank
“Everyone else made money. Why is it all blue?”
The ants who jumped into the stock market this year were in trouble after accepting the report cards that did not meet expectations. Although the KOSPI index has risen sharply this year, the perceived return is not high. In fact, it was found that only 3 out of 10 people had a higher return than the increase rate of the KOSPI index this year. There is also an analysis that the phenomenon of the rich rich and poor is intensifying in the market led by some large stocks.
As a result of examining the yield by stock this year through F&Guide, a financial information company on the 28th, only 274 of the 770 stocks listed on the securities market (excluding those that have been suspended from trading) have exceeded the KOSPI increase rate of 8.67% since the beginning of the year. In total, 496 and 7 out of 10 failed to keep up with the index return. There were also 243 stocks with negative returns. This is why the KOSPI index broke a record high every day, but the perceived rate of return of ants (individual investors) was not.
Seongan is the most profitable stock this year. Lee Jae-myeong is classified as a theme stock for Gyeongji Temple, and the stock price soared by 172.91%. Hyundai B&G Steel, which decided to take over LG Hausys’ automotive materials business, also jumped 117.33% this year as its stock price rose sharply in just a few days. Among the stocks with a market capitalization of over 1 trillion won, Hyundai Wia (77.57%), Kumho Petrochemical (55.17%), Hanwha Aerospace (49.47%), SK Innovation (47.89%), and Hyosung Advanced Materials (45.64%) stand out. Showed. The stocks that individuals bought the most were different from those with higher returns. The top stocks for individual net buying are Naver, SK, Kumho Petroleum, LG Innotek, and KT.
Shinpoong Pharmaceutical, one of the items that ants liked last year, was named the most crashed item this year. Shinpoong Pharmaceutical’s share price fell 27.74% this year alone. Biogen companies (-26.76%), United Pharmaceuticals (-20.63%), Jeil Pharmaceuticals (-20.69%), and Ilyang Pharmaceuticals (-20.06%) ranked in the bottom line.
The KOSDAQ index rose only 1.81% compared to the beginning of the year as the market led by large-cap stocks continued. Thanks to this, 778 of the total 1389 stocks, 56.01%, exceeded the KOSDAQ index. However, there were 478 stocks (34.41%) that recorded negative returns, which was higher than the KOSPI (31.56%).
The stocks that made high profits were also more of KOSDAQ companies. It was found that Susan I&T made 301.52% of profit this year. Total Soft (219.68%), Dev Sisters (171.97%), Korea Pharma (165.32%), Interpark (112.09%), etc., recorded more than 100% of the stock.
The last place in the yield was Oscotek (-36.05%). Gene Matrix (-34.10%) and N2Tek (-32.67%) followed. Since some large stocks led the index to rise, it is highly likely that the stocks held by investors have failed to meet expectations. “The market led by the existing leaders will continue for the time being. ”Analyzed.
Reporter Park Jae-won [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution